The United Kingdom has a prestigious track record in genetic and genomic research, with the structure of DNA, and delivery of a third of the human genome being significant landmarks. UK genomic research benefits from a variety of funding sources in both the public and private sector, and efforts to co-ordinate research strategies. Here we describe how this investment has impacted on the UK research capacity and highlight examples of progress in translating genetic information into improved healthcare.